Autor: "Mohd Taib NA" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Understanding How Malaysian Women Appraise their Breast Cancer Symptoms: A Narrative Approach.
Autorzy:: Wan, Mamat WH
Lund, S.
Jarrett, N.
Mohd, Taib NA
Duke, S.; Pokaż więcej
Temat:: BREAST cancer
MEDICAL personnel
SOCIAL norms
EARLY detection of cancer
MALAYSIANS
Źródło:: IIUM Medical Journal Malaysia; Apr2022, Vol. 21 Issue 2, p81-87, 7p
Terminy geograficzne:: MALAYSIA

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: PCN33 - Cost Effectiveness of Brca Mutation Testing for Early-Stage Breast Cancer Patients with Family History in Malaysia
Autorzy:: Lim, KK
Yoon, SY
Teo, SH
Mohd Taib, NA
Shabaruddin, FH
Dahlui, M
Chaiyakunapruk, N; Pokaż więcej
Źródło:: In Value in Health November 2016 19(7):A889-A889

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: A Delphi technique toward the development of a cognitive intervention framework module for breast cancer survivors with cognitive impairment following chemotherapy.
Autorzy:: Syed Alwi SM; Department of Surgery, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.
Mazlan M; Department of Rehabilitation Medicine, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.
Mohd Taib NA; Department of Surgery, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.
Che Din N; School of Healthcare Sciences, Faculty of Health Science, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Narayanan V; Department of Surgery, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Nov 17; Vol. 17 (11), pp. e0277056. Date of Electronic Publication: 2022 Nov 17 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Cancer Survivors*
Breast Neoplasms*/complications
Breast Neoplasms*/drug therapy
Breast Neoplasms*/psychology
Cognitive Dysfunction*/chemically induced
Cognitive Dysfunction*/therapy
Humans ; Female ; Delphi Technique ; Quality of Life ; Cognition

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Impact of preoperative magnetic resonance imaging on surgery and eligibility for intraoperative radiotherapy in early breast cancer.
Autorzy:: Chan WY; Department of Biomedical Imaging, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Cheah WK; Department of Biomedical Imaging, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Ramli Hamid MT; Department of Biomedical Imaging, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.; Department of Radiology, Faculty of Medicine, University Teknologi MARA, Sungai Buloh, Selangor, Malaysia.
Md Shah MN; Department of Biomedical Imaging, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Fadzli F; Department of Biomedical Imaging, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Kaur S; Department of Biomedical Imaging, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
See MH; Department of Surgery, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Mohd Taib NA; Department of Surgery, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Rahmat K; Department of Biomedical Imaging, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Oct 18; Vol. 17 (10), pp. e0274385. Date of Electronic Publication: 2022 Oct 18 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Humans ; Female ; Mastectomy, Segmental/methods ; Mammography ; Radiotherapy, Adjuvant/methods ; Magnetic Resonance Imaging/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Breast cancer risks associated with missense variants in breast cancer susceptibility genes.
Autorzy:: Dorling L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Carvalho S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Allen J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
Fortuno C; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
González-Neira A; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
Heijl SM; Bio-Prodict, Nijmegen, The Netherlands.
Adank MA; Family Cancer Clinic, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Amsterdam, 1066 CX, The Netherlands.
Ahearn TU; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20850, USA.
Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, M5S 1A8, Canada.
Auvinen P; Translational Cancer Research Area, University of Eastern Finland, 70210, Kuopio, Finland.; Institute of Clinical Medicine, Oncology, University of Eastern Finland, 70210, Kuopio, Finland.; Department of Oncology, Cancer Center, Kuopio University Hospital, 70210, Kuopio, Finland.
Becher H; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
Beckmann MW; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), 91054, Erlangen, Germany.
Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Bermisheva M; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, 450054, Russia.
Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, 30625, Hannover, Germany.; Gynaecology Research Unit, Hannover Medical School, 30625, Hannover, Germany.; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, 223040, Minsk, Belarus.
Bojesen SE; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Bremer M; Department of Radiation Oncology, Hannover Medical School, 30625, Hannover, Germany.
Briceno I; Medical Faculty, Universidad de La Sabana, 140013, Bogota, Colombia.
Camp NJ; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA.
Campbell A; Centre for Genomic and Experimental Medicine, Institute of Genetics & Cancer, The University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK.; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, EH16 4UX, UK.
Castelao JE; Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, 36312, Vigo, Spain.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
Chanock SJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20850, USA.
Chenevix-Trench G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
Collée JM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65, Stockholm, Sweden.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Dörk T; Gynaecology Research Unit, Hannover Medical School, 30625, Hannover, Germany.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65, Stockholm, Sweden.
Evans DG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; Nightingale & Genesis Prevention Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.
Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), 91054, Erlangen, Germany.; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Figueroa J; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20850, USA.; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, EH16 4UX, UK.; Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, EH4 2XR, UK.
Flyger H; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730, Herlev, Denmark.
Gabrielson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65, Stockholm, Sweden.
Gago-Dominguez M; Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, , 15706, Santiago de Compostela, Spain.; Moores Cancer Center, University of California San Diego, La Jolla, CA, 92037, USA.
García-Closas M; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20850, USA.
Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, 3010, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, 3168, Australia.
Glendon G; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada.
Guénel P; Team 'Exposome and Heredity', CESP, Inserm, Gustave Roussy, University Paris-Saclay, UVSQ, Villejuif, France.
Gündert M; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, 69120, Heidelberg, Germany.; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Germany.
Hadjisavvas A; Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 2371, Nicosia, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, 2371, Nicosia, Cyprus.
Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65, Stockholm, Sweden.; Department of Oncology, 118 83, Södersjukhuset, Stockholm, Sweden.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Harkness EF; Nightingale & Genesis Prevention Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK.
Hartman M; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, 117549, Singapore.; Department of Surgery, National University Health System, Singapore, 119228, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, 119228, Singapore.
Hogervorst FBL; Family Cancer Clinic, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Amsterdam, 1066 CX, The Netherlands.
Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, 3015 GD, The Netherlands.
Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376, Stuttgart, Germany.; University of Tübingen, 72074, Tübingen, Germany.
Howell A; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; Division of Cancer Sciences, University of Manchester, Manchester, M13 9PL, UK.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, 71-252, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, 71-252, Szczecin, Poland.
Jung A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Khusnutdinova E; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, 450054, Russia.; Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, 450000, Russia.
Kim SW; Department of Surgery, Daerim Saint Mary's Hospital, Seoul, 07442, Korea.
Ko YD; Department of Internal Medicine, Johanniter GmbH Bonn, Johanniter Krankenhaus, 53113, Bonn, Germany.
Kristensen VN; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450, Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital and University of Oslo, 0379, Oslo, Norway.
Lakeman IMM; Department of Human Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Li J; Department of Surgery, National University Health System, Singapore, 119228, Singapore.; Human Genetics Division, Genome Institute of Singapore, Singapore, 138672, Singapore.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Loizidou MA; Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 2371, Nicosia, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, 2371, Nicosia, Cyprus.
Lophatananon A; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK.
Lubiński J; Department of Genetics and Pathology, Pomeranian Medical University, 71-252, Szczecin, Poland.
Luccarini C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Madsen MJ; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA.
Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, 70210, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, 70210, Kuopio, Finland.; Biobank of Eastern Finland, Kuopio University Hospital, Kuopio, Finland.
Manoochehri M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Margolin S; Department of Oncology, 118 83, Södersjukhuset, Stockholm, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 118 83, Stockholm, Sweden.
Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, 711 10, Heraklion, Greece.
Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, 3010, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, 3168, Australia.
Mohd Taib NA; Breast Cancer Research Unit, Faculty of Medicine, University Malaya Cancer Research Institute, University of Malaya, 50603, Kuala Lumpur, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
Muir K; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, 00290, Helsinki, Finland.
Newman WG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.
Oosterwijk JC; Department of Genetics, University Medical Center Groningen, University Groningen, Groningen, 9713 GZ, The Netherlands.
Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, 03080, Korea.; Convergence Graduate Program in Innovative Medical Science, Seoul National University College of Medicine, Seoul, 03080, South Korea.; Cancer Research Institute, Seoul National University, Seoul, 03080, Korea.
Peterlongo P; Genome Diagnostics Program, IFOM - the FIRC Institute of Molecular Oncology, 20139, Milan, Italy.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), 20133, Milan, Italy.
Saloustros E; Department of Oncology, University Hospital of Larissa, 411 10, Larissa, Greece.
Sawyer EJ; School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, King's College London, London, UK.
Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Sim X; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, 117549, Singapore.
Southey MC; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, 3168, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, 3010, Australia.
Surowy H; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, 69120, Heidelberg, Germany.
Suvanto M; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, 00290, Helsinki, Finland.
Tomlinson I; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, OX3 7BN, UK.
Torres D; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Institute of Human Genetics, Pontificia Universidad Javeriana, 110231, Bogota, Colombia.
Truong T; Team 'Exposome and Heredity', CESP, Inserm, Gustave Roussy, University Paris-Saclay, UVSQ, Villejuif, France.
van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Waltes R; Gynaecology Research Unit, Hannover Medical School, 30625, Hannover, Germany.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Yang XR; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20850, USA.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Amsterdam, 1066 CX, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Amsterdam, 1066 CX, The Netherlands.
Benitez J; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Biomedical Network On Rare Diseases (CIBERER), 28029, Madrid, Spain.
Vroling B; Bio-Prodict, Nijmegen, The Netherlands.; Centre for Molecular and Biomolecular Informatics (CMBI), Radboud University Medical Center, Nijmegen, The Netherlands.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Teo SH; Breast Cancer Research Unit, Faculty of Medicine, University Malaya Cancer Research Institute, University of Malaya, 50603, Kuala Lumpur, Malaysia.; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, 47500, Selangor, Malaysia.
Kvist A; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, 22381, Lund, Sweden.
de la Hoya M; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040, Madrid, Spain.
Devilee P; Department of Human Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK. .; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK. .; Pokaż więcej
Corporate Authors:: NBCS Collaborators
kConFab Investigators
SGBCC Investigators
Źródło:: Genome medicine [Genome Med] 2022 May 18; Vol. 14 (1), pp. 51. Date of Electronic Publication: 2022 May 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/genetics
Case-Control Studies ; Female ; Genetic Predisposition to Disease ; Humans ; Mutation, Missense

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification.
Autorzy:: Ho PJ; Genome Institute of Singapore, Human Genetics, Singapore, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore.
Ho WK; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.; School of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, 43500, Semenyih, Selangor, Malaysia.
Khng AJ; Genome Institute of Singapore, Human Genetics, Singapore, Singapore.
Yeoh YS; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore.
Tan BK; Department of General Surgery, Sengkang General Hospital, Singapore, Singapore.; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.; Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Tan EY; Department of General Surgery, Tan Tock Seng Hospital, Singapore, 308433, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technology University, Singapore, Singapore.; Institute of Molecular and Cell Biology, Singapore, Singapore.
Lim GH; KK Breast Department, KK Women's and Children's Hospital, Singapore, 229899, Singapore.
Tan SM; Division of Breast Surgery, Changi General Hospital, Singapore, Singapore.
Tan VKM; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.; Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Yip CH; Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia.
Mohd-Taib NA; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Universiti Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Wong FY; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Lim EH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Ngeow J; Lee Kong Chian School of Medicine, Nanyang Technology University, Singapore, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Cancer Genetics Service, National Cancer Centre Singapore, Singapore, Singapore.
Chay WY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Leong LCH; Department of Diagnostic Radiology, Singapore General Hospital, Singapore, Singapore.
Yong WS; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Seah CM; Division of Breast Surgery, Changi General Hospital, Singapore, Singapore.
Tang SW; Department of Surgery, University Surgical Cluster, National University Hospital, Singapore, Singapore.
Ng CWQ; Department of Surgery, University Surgical Cluster, National University Hospital, Singapore, Singapore.
Yan Z; KK Breast Department, KK Women's and Children's Hospital, Singapore, 229899, Singapore.
Lee JA; KK Breast Department, KK Women's and Children's Hospital, Singapore, 229899, Singapore.
Rahmat K; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Islam T; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Universiti Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Hassan T; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Tai MC; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Khor CC; Genome Institute of Singapore, Human Genetics, Singapore, Singapore.
Yuan JM; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA.
Koh WP; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore, 117609, Singapore.
Sim X; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Teo SH; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, Jalan Universiti, 50630, Kuala Lumpur, Malaysia.
Li J; Genome Institute of Singapore, Human Genetics, Singapore, Singapore. .; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore. .
Hartman M; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore.; Department of Surgery, University Surgical Cluster, National University Hospital, Singapore, Singapore.; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2022 Apr 26; Vol. 20 (1), pp. 150. Date of Electronic Publication: 2022 Apr 26.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/diagnosis
Breast Neoplasms*/epidemiology
Breast Neoplasms*/genetics
Asian People ; Female ; Genetic Predisposition to Disease/genetics ; Humans ; Male ; Risk Assessment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
Autorzy:: Padmanabhan H; Genetic Counselling Unit, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Hassan NT; Genetic Counselling Unit, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Wong SW; Genetic Counselling Unit, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Lee YQ; Genetic Counselling Unit, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Lim J; Core Laboratory Unit, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Hasan SN; Core Laboratory Unit, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Yip CH; Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia.
Teo SH; Cancer Prevention and Population Science Unit, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Thong MK; Department of Paediatrics, Genetic Medicine Unit, Faculty of Medicine, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Mohd Taib NA; Department of Surgery, Faculty of Medicine, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Yoon SY; Genetic Counselling Unit, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Feb 15; Vol. 17 (2), pp. e0263675. Date of Electronic Publication: 2022 Feb 15 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Breast Neoplasms/*psychology
Fanconi Anemia Complementation Group N Protein/*genetics
Genetic Counseling/*psychology
Adult ; Breast Neoplasms/genetics ; Female ; Genetic Predisposition to Disease ; Genetic Variation ; Humans ; Malaysia ; Middle Aged ; Risk Assessment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Decision-making for Risk-reducing Salpingo-oophorectomy (RRSO) in Southeast Asian BRCA Mutation Carriers With Breast Cancer: A Qualitative Study.
Autorzy:: Sa'at H; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Lee YK; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Yoon SY; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Wong SW; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Woo YL; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Barlow-Stewart K; Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Mohd Taib NA; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. .; University of Malaya Cancer Research Institute, University of Malaya, Kuala Lumpur, Malaysia. .; Pokaż więcej
Źródło:: International journal of behavioral medicine [Int J Behav Med] 2022 Feb; Vol. 29 (1), pp. 1-13. Date of Electronic Publication: 2021 Mar 31.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/genetics
Breast Neoplasms*/prevention & control
Salpingo-oophorectomy*
Female ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Heterozygote ; Humans ; Malaysia ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Changes in Dietary Intake of Breast Cancer Survivors: Early Findings of a Malaysian Breast Cancer Prospective Cohort Study.
Autorzy:: Kiew SJ; Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Mohd Taib NA; UM Cancer Research Institute and Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Islam T; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Abdul Majid H; Centre for Population Health and Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Department of Nutrition, Faculty of Public Health, University of Airlangga, Surabaya, Indonesia.; Pokaż więcej
Corporate Authors:: MyBCC study group
Źródło:: Nutrition and cancer [Nutr Cancer] 2022; Vol. 74 (7), pp. 2470-2478. Date of Electronic Publication: 2021 Dec 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*
Cancer Survivors*
Body Mass Index ; Calcium ; Calcium, Dietary ; Cohort Studies ; Diet ; Dietary Fiber ; Eating ; Energy Intake ; Female ; Humans ; Obesity ; Prospective Studies ; Survivors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Germline breast cancer susceptibility genes, tumor characteristics, and survival.
Autorzy:: Ho PJ; Genome Institute of Singapore, Human Genetics, Singapore, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
Khng AJ; Genome Institute of Singapore, Human Genetics, Singapore, Singapore.
Loh HW; Genome Institute of Singapore, Human Genetics, Singapore, Singapore.
Ho WK; School of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, 43500, Semenyih, Selangor, Malaysia.; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Yip CH; Subang Jaya Medical Centre, Jalan SS 12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Mohd-Taib NA; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; UM Cancer Research Institute, Kuala Lumpur, Malaysia.
Tan VKM; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Tan BK; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of General Surgery, Sengkang General Hospital, Singapore, Singapore.
Tan SM; Division of Breast Surgery, Changi General Hospital, Singapore, Singapore.
Tan EY; Department of General Surgery, Tan Tock Seng Hospital, Singapore, 308433, Singapore.; Lee Kong Chian School of Medicine, Singapore, Singapore.; Institute of Molecular and Cell Biology, Singapore, Singapore.
Lim SH; KK Breast Department, KK Women's and Children's Hospital, Singapore, 229899, Singapore.
Jamaris S; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; UM Cancer Research Institute, Kuala Lumpur, Malaysia.
Sim Y; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Wong FY; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Ngeow J; Lee Kong Chian School of Medicine, Nanyang Technology University, Singapore, Singapore.; Cancer Genetics Service, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Clinical Program, Duke NUS, Singapore, Singapore.
Lim EH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Tai MC; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Wijaya EA; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Lee SC; Department of Hematology-oncology, National University Cancer Institute, National University Health System, Singapore, 119074, Singapore.
Chan CW; Department of Surgery, University Surgical Cluster, National University Hospital, Singapore, Singapore.
Buhari SA; Department of Surgery, University Surgical Cluster, National University Hospital, Singapore, Singapore.
Chan PMY; Department of General Surgery, Tan Tock Seng Hospital, Singapore, 308433, Singapore.
Chen JJC; Department of General Surgery, Tan Tock Seng Hospital, Singapore, 308433, Singapore.
Seah JCM; Division of Breast Surgery, Changi General Hospital, Singapore, Singapore.
Lee WP; Division of Breast Surgery, Changi General Hospital, Singapore, Singapore.
Mok CW; Division of Breast Surgery, Changi General Hospital, Singapore, Singapore.
Lim GH; KK Breast Department, KK Women's and Children's Hospital, Singapore, 229899, Singapore.
Woo E; KK Breast Department, KK Women's and Children's Hospital, Singapore, 229899, Singapore.
Kim SW; Department of Surgery, Breast Care Center, Daerim St. Mary's Hospital, Seoul, Korea.
Lee JW; Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea.
Lee MH; Department of Surgery, Soonchunhyang University and Hospital, Seoul, Republic of Korea.
Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Teo SH; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, Jalan Universiti, 50630, Kuala Lumpur, Malaysia.
Li J; Genome Institute of Singapore, Human Genetics, Singapore, Singapore. .; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore. .
Hartman M; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.; Department of Surgery, University Surgical Cluster, National University Hospital, Singapore, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore.; Pokaż więcej
Źródło:: Genome medicine [Genome Med] 2021 Dec 02; Vol. 13 (1), pp. 185. Date of Electronic Publication: 2021 Dec 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/pathology
BRCA1 Protein/genetics ; Female ; Genetic Predisposition to Disease ; Genetic Testing ; Germ Cells ; Germ-Line Mutation ; Humans ; Odds Ratio

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Chemotherapy-related cognitive impairment (CRCI) among early-stage breast cancer survivors in Malaysia.
Autorzy:: Syed Alwi SM; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Narayanan V; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Mohd Taib NA; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Che Din N; School of Healthcare Sciences, Faculty of Health Science, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.; Pokaż więcej
Źródło:: Journal of clinical and experimental neuropsychology [J Clin Exp Neuropsychol] 2021 Jul; Vol. 43 (5), pp. 534-545. Date of Electronic Publication: 2021 Aug 09.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/complications
Breast Neoplasms*/drug therapy
Cancer Survivors*
Chemotherapy-Related Cognitive Impairment*
Cross-Sectional Studies ; Female ; Humans ; Malaysia/epidemiology ; Quality of Life

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
Autorzy:: Park J; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.; BK21plus Biomedical Science Project, Seoul National University College of Medicine, Seoul 03080, Korea.
Choi JY; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.; BK21plus Biomedical Science Project, Seoul National University College of Medicine, Seoul 03080, Korea.; Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.
Choi J; Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul 03080, Korea.
Chung S; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.
Song N; College of Pharmacy, Chungbuk National University, Cheongju-si 28160, Korea.
Park SK; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
Han W; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.; Department of Surgery, Seoul National University College of Medicine, Seoul 03080, Korea.
Noh DY; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.; Department of Surgery, Seoul National University College of Medicine, Seoul 03080, Korea.
Ahn SH; Department of Surgery, Medicine and ASAN Medical Center, University of Ulsan College, Seoul 05505, Korea.
Lee JW; Department of Surgery, Medicine and ASAN Medical Center, University of Ulsan College, Seoul 05505, Korea.
Kim MK; Division of Cancer Epidemiology and Management, National Cancer Center, Goyang-si 10408, Korea.
Jee SH; Department of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul 03722, Korea.
Wen W; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia 23462, Cyprus.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Conroy DM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Harrington PA; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Mayes R; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65 Stockholm, Sweden.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65 Stockholm, Sweden.; Department of Oncology, Södersjukhuset, 118 83 Stockholm, Sweden.
Teras LR; Department of Population Science, American Cancer Society, Atlanta, GA 30303, USA.
Patel AV; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
Sawyer EJ; School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, King's College London, London SE1 9RT, UK.
Roylance R; Department of Oncology, UCLH Foundation Trust, London NW1 2PG, UK.
Bojesen SE; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Flyger H; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
Lambrechts D; VIB Center for Cancer Biology, 3001 Leuve, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium.
Baten A; Department of Radiotherapy Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, 3000 Leuven, Belgium.
Matsuo K; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Ito H; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Guénel P; Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, INSERM, University Paris-Saclay, 94805 Villejuif, France.
Truong T; Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, INSERM, University Paris-Saclay, 94805 Villejuif, France.
Keeman R; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Tseng CC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Cox A; Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2TN, UK.
Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield S10 2TN, UK.
kConFab Investigators; Peter MacCallum Cancer Center, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3000, Australia.
Andrulis IL; Fred A, Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia.
Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC 3010, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia.
Wu PE; Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Shen CY; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.; School of Public Health, China Medical University, Taichung 404, Taiwan.
Fasching PA; Department of Medicine Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Ekici AB; Institute of Human Genetics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Muir K; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
Lophatananon A; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK.
Swerdlow AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK.; Division of Breast Cancer Research, The Institute of Cancer Research, London SW7 3RP, UK.
Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tübingen, 72074 Tübingen, Germany.
Ko YD; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, 53177 Bonn, Germany.
Hartman M; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117549, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore 119228, Singapore.; Department of Surgery, National University Health System, Singapore 119228, Singapore.
Li J; Human Genetics Division, Genome Institute of Singapore, Singapore 138672, Singapore.
Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, 70210 Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, 70210 Kuopio, Finland.; Biobank of Eastern Finland, Kuopio University Hospital, 70210 Kuopio, Finland.
Hartikainen JM; Translational Cancer Research Area, University of Eastern Finland, 70210 Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, 70210 Kuopio, Finland.
Benitez J; Biomedical Network on Rare Diseases (CIBERER), 28029 Madrid, Spain.; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
González-Neira A; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Dörk T; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.
Bogdanova NV; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.; NN Alexandrov Research Institute of Oncology and Medical Radiology, 223040 Minsk, Belarus.
Teo SH; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya 47500, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
Mohd Taib NA; Breast Cancer Research Unit, University Malaya Cancer Research Institute, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
Fletcher O; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW7 3RP, UK.
Johnson N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW7 3RP, UK.
Grip M; Department of Surgery, Oulu University Hospital, University of Oulu, 90220 Oulu, Finland.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, 90570 Oulu, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu 90570, Finland.
Blomqvist C; Department of Oncology, Helsinki University Hospital, University of Helsinki, 00290 Helsinki, Finland.; Department of Oncology, Örebro University Hospital, 70185 Örebro, Sweden.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, 00290 Helsinki, Finland.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Wendt C; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 118 83 Stockholm, Sweden.
Kristensen VN; Department of Medical Genetics, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0372 Oslo, Norway.
Nbcs Collaborators; Department of Medical Genetics, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0372 Oslo, Norway.; Department of Research, Vestre Viken Hospital, 3004 Drammen, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0450 Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, 0450 Oslo, Norway.; Section for Breast- and Endocrine Surgery, Department of Cancer, Division of Surgery, Cancer and Transplantation Medicine, Oslo University Hospital-Ullevål, 0450 Oslo, Norway.; Department of Radiology and Nuclear Medicine, Oslo University Hospital, 0450 Oslo, Norway.; Department of Pathology at Akershus University Hospital, 1478 Lørenskog, Norway.; Department of Oncology, Division of Surgery and Cancer and Transplantation Medicine, University Hospital-Radiumhospitalet, 0405 Oslo, Norway.; National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Oslo University Hospital, 0405 Oslo, Norway.; Department of Oncology, Akershus University Hospital, 1478 Lørenskog, Norway.; Oslo Breast Cancer Research Consortium, Oslo University Hospital, 0405 Oslo, Norway.
Tollenaar RAEM; Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy.
Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Manoochehri M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Lacey JV; Department of Computational and Quantitative Medicine, City of Hope, Duarte, CA 91010, USA.; City of Hope Comprehensive Cancer Center, City of Hope, Duarte, CA 91010, USA.
Martinez ME; Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA.; Herbert Wertheim School of Public Health and Longevity Science, University of California San Diego, La Jolla, CA 92161, USA.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Yoo KY; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
Kang D; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 May 14; Vol. 13 (10). Date of Electronic Publication: 2021 May 14.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Two truncating variants in FANCC and breast cancer risk.
Autorzy:: Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. .
Peterlongo P; Genome Diagnostics Program, IFOM - the FIRC Institute of Molecular Oncology, Milan, Italy.
Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Ahearn T; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Anton-Culver H; Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA.
Arndt V; Division of Clinical Epidemiology and Aging Research, C070, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Aronson KJ; Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, ON, Canada.
Augustinsson A; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Freeman LEB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Beckmann MW; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Beeghly-Fadiel A; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Bermisheva M; Institute of Biochemistry and Genetics of the Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
Blomqvist C; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.; Department of Oncology, Örebro University Hospital, Örebro, Sweden.
Bogdanova NV; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
Bojesen SE; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; iFIT Cluster of Excellence, University of Tübingen, Tübingen, Germany.
Brenner H; Division of Clinical Epidemiology and Aging Research, C070, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Burwinkel B; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.
Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Chan TL; Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Choi JY; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Christiansen H; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
Clarke CL; Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
Dos-Santos-Silva I; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Dwek M; Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK.
Eccles DM; Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
Ekici AB; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Evans DG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA.
Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK.; Cancer Research UK Edinburgh Centre, Edinburgh, UK.
Flyger H; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
Fritschi L; School of Public Health, Curtin University, Perth, Western Australia, Australia.
Gabrielson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Gago-Dominguez M; Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Gao C; Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Gapstur SM; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
García-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
García-Sáenz JA; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Gaudet MM; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Goldberg MS; Department of Medicine, McGill University, Montréal, QC, Canada.; Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, QC, Canada.
Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Guénel P; Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
Haeberle L; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Håkansson N; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hartman M; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.; Department of Surgery, National University Health System, Singapore, Singapore.
Hauke J; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Hein A; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Hillemanns P; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Hogervorst FBL; Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Howell T; Division of Cancer Sciences, University of Manchester, Manchester, UK.
Huo D; Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA.
Ito H; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Iwasaki M; Division of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
Janni W; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
John EM; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Jung A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kang D; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kapoor PM; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.
Khusnutdinova E; Institute of Biochemistry and Genetics of the Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.; Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia.
Kim SW; Department of Surgery, Daerim Saint Mary's Hospital, Seoul, Korea.
Kitahara CM; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Koutros S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Kraft P; Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Kristensen VN; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Kwong A; Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.; Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong.; Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
Lambrechts D; VIB Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
Marchand LL; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Li J; Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore.
Lindström S; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Linet M; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Lo WY; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.
Long J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Lophatananon A; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Lubiński J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Manoochehri M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Manoukian S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Margolin S; Department of Oncology, Södersjukhuset, Stockholm, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Martinez E; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.; Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA.
Matsuo K; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
Meindl A; Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany.
Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK.
Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
Mohd Taib NA; Breast Cancer Research Unit, UM Cancer Research Institute, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
Muir K; Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Mulligan AM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Neven P; Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Newman WG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Offit K; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Olopade OI; Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA.
Olshan AF; Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Olsson H; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Park SK; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Park-Simon TW; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Peto J; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Plaseska-Karanfilska D; Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia.
Pohl-Rescigno E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Presneau N; Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK.
Rack B; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Rashid MU; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan.
Rennert G; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Rennert HS; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Romero A; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Ruebner M; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Saloustros E; Department of Oncology, University Hospital of Larissa, Larissa, Greece.
Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Schneider MO; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Schoemaker MJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Scott C; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Shen CY; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.; School of Public Health, China Medical University, Taichung, Taiwan.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, QC, Canada.
Slager S; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Smichkoska S; Ss. Cyril and Methodius University in Skopje, Medical Faculty, University Clinic of Radiotherapy and Oncology, Skopje, Republic of Macedonia.
Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
Spinelli JJ; Population Oncology, BC Cancer, Vancouver, BC, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Stone J; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Western Australia, Australia.
Surowy H; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.
Swerdlow AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
Tamimi RM; Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Tapper WJ; Faculty of Medicine, University of Southampton, Southampton, UK.
Teo SH; Breast Cancer Research Unit, UM Cancer Research Institute, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Terry MB; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Toland AE; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Tollenaar RAEM; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Torres D; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
Torres-Mejía G; Center for Population Health Research, National Institute of Public Health, Mexico, Mexico.
Troester MA; Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Truong T; Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
Tsugane S; Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Untch M; Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin, Germany.
Vachon CM; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
Ouweland AMWVD; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Veen EMV; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Vijai J; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Wendt C; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Wolk A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Yu JC; Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Ziogas A; Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA.
Ziv E; Department of Medicine, Institute for Human Genetics, UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Schindler D; Institute of Human Genetics, Biocenter, University of Würzburg, Würzburg, Germany.
Devilee P; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Pokaż więcej
Corporate Authors:: ABCTB Investigators
NBCS Collaborators
Źródło:: Scientific reports [Sci Rep] 2019 Aug 29; Vol. 9 (1), pp. 12524. Date of Electronic Publication: 2019 Aug 29.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Sequence Deletion*
Breast Neoplasms/*genetics
Fanconi Anemia Complementation Group C Protein/*genetics
BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Breast Neoplasms/metabolism ; Case-Control Studies ; Fanconi Anemia/genetics ; Fanconi Anemia Complementation Group C Protein/metabolism ; Female ; Genetic Predisposition to Disease ; Genetic Variation ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Patient-reported outcome measures among breast cancer survivors: A cross-sectional comparison between Malaysia and high-income countries.
Autorzy:: Rajaram N; Breast Cancer Research Group, Cancer Research Malaysia, Subang Jaya, Malaysia.
Lim ZY; Breast Cancer Research Group, Cancer Research Malaysia, Subang Jaya, Malaysia.
Song CV; Breast Cancer Research Group, Cancer Research Malaysia, Subang Jaya, Malaysia.
Kaur R; Breast Cancer Welfare Association, Petaling Jaya, Malaysia.
Mohd Taib NA; Department of Surgery, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Muhamad M; KanWork Cancer Society, Seri Kembangan, Malaysia.; Faculty of Education, Universiti Putra Malaysia, Seri Kembangan, Malaysia.
Ong WL; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
Schouwenburg M; Breast Cancer Working Group, International Consortium for Health Outcomes Measurement, Cambridge, Massachusetts, USA.; Dutch Institute for Clinical Auditing, Amsterdam, The Netherlands.
See MH; Department of Surgery, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Teo SH; Breast Cancer Research Group, Cancer Research Malaysia, Subang Jaya, Malaysia.; Department of Surgery, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Saunders C; School of Surgery, University of Western Australia, Subiaco, Australia.
Yip CH; Department of Surgery, Subang Jaya Medical Centre, Subang Jaya, Malaysia.; Pokaż więcej
Źródło:: Psycho-oncology [Psychooncology] 2019 Jan; Vol. 28 (1), pp. 147-153. Date of Electronic Publication: 2018 Oct 30.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Patient Reported Outcome Measures*
Breast Neoplasms/*psychology
Cancer Survivors/*psychology
Quality of Life/*psychology
Adaptation, Psychological ; Adult ; Body Image/psychology ; Breast Neoplasms/therapy ; Cancer Survivors/statistics & numerical data ; Cross-Sectional Studies ; Developed Countries ; Female ; Humans ; Income/statistics & numerical data ; Malaysia ; Middle Aged ; Self Concept ; Socioeconomic Factors ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: A case-control study of breast cancer risk factors in 7,663 women in Malaysia.
Autorzy:: Tan MM; Department of Applied Mathematics, Faculty of Engineering, University of Nottingham Malaysia Campus, Semenyih, Selangor, Malaysia.; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Ho WK; Department of Applied Mathematics, Faculty of Engineering, University of Nottingham Malaysia Campus, Semenyih, Selangor, Malaysia.; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Yoon SY; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Mariapun S; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Hasan SN; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Lee DS; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Hassan T; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Lee SY; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Phuah SY; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Sivanandan K; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Ng PP; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Rajaram N; Department of Applied Mathematics, Faculty of Engineering, University of Nottingham Malaysia Campus, Semenyih, Selangor, Malaysia.; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Jaganathan M; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Jamaris S; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Islam T; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Rahmat K; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Biomedical Imaging Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Fadzli F; Biomedical Imaging Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Vijayananthan A; Biomedical Imaging Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Rajadurai P; Sime Darby Medical Centre, Subang Jaya, Selangor, Malaysia.; Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia Campus, Subang Jaya, Selangor, Malaysia.
See MH; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Thong MK; Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Mohd Taib NA; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Yip CH; Sime Darby Medical Centre, Subang Jaya, Selangor, Malaysia.
Teo SH; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2018 Sep 14; Vol. 13 (9), pp. e0203469. Date of Electronic Publication: 2018 Sep 14 (Print Publication: 2018).
Typ publikacji:: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms/*epidemiology
Adult ; Aged ; Breast Feeding ; Case-Control Studies ; Female ; Humans ; Malaysia/epidemiology ; Middle Aged ; Risk Factors ; Soybean Proteins/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia.
Autorzy:: Mohd Mujar NM; Cluster of Healthy Lifestyle, Advanced Medical and Dental Institute, University Science of Malaysia, Penang, Malaysia.
Dahlui M; Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Emran NA; Ministry of Health, Putrajaya, Malaysia.
Abdul Hadi I; Ministry of Health, Putrajaya, Malaysia.
Wai YY; Ministry of Health, Putrajaya, Malaysia.
Arulanantham S; Ministry of Health, Putrajaya, Malaysia.
Hooi CC; Ministry of Health, Putrajaya, Malaysia.
Mohd Taib NA; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2017 Apr 27; Vol. 12 (4), pp. e0176394. Date of Electronic Publication: 2017 Apr 27 (Print Publication: 2017).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms/*diagnosis
Complementary Therapies/*statistics & numerical data
Hospitals, Public/*statistics & numerical data
Adult ; Aged ; Breast Neoplasms/therapy ; Early Detection of Cancer ; Female ; Humans ; Malaysia ; Middle Aged ; Prognosis ; Surveys and Questionnaires ; Time Factors ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Characterization of BRCA1 and BRCA2 variants in multi-ethnic Asian cohort from a Malaysian case-control study.
Autorzy:: Lai KN; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Ho WK; Department of Applied Mathematics, Faculty of Engineering, The University of Nottingham Malaysia Campus, 43500, Semenyih, Selangor, Malaysia.
Kang IN; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Kang PC; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Phuah SY; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Mariapun S; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Yip CH; Subang Jaya Medical Centre, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia.
Mohd Taib NA; Breast Cancer Research Unit, University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, 50603, Kuala Lumpur, Malaysia.; Department of Surgery, Faculty of Medicine, University Malaya Medical Centre, 50603, Kuala Lumpur, Malaysia.
Teo SH; Cancer Research Malaysia, 1 Jalan SS12/1A, 47500, Subang Jaya, Selangor, Malaysia. .; Breast Cancer Research Unit, University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, 50603, Kuala Lumpur, Malaysia. .; Department of Surgery, Faculty of Medicine, University Malaya Medical Centre, 50603, Kuala Lumpur, Malaysia. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2017 Feb 22; Vol. 17 (1), pp. 149. Date of Electronic Publication: 2017 Feb 22.
Typ publikacji:: Journal Article
MeSH Terms:: BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Breast Neoplasms/*genetics
Ethnicity/*genetics
Amino Acid Substitution ; Breast Neoplasms/ethnology ; Case-Control Studies ; Female ; Genetic Association Studies ; Genetic Predisposition to Disease ; Humans ; Malaysia/ethnology ; Male ; Oligonucleotide Array Sequence Analysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history.
Autorzy:: Toh GT; Cancer Research Initiatives Foundation (CARIF), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia.
Kang P
Lee SS
Lee DS
Lee SY
Selamat S
Mohd Taib NA
Yoon SY
Yip CH
Teo SH; Pokaż więcej
Źródło:: PloS one [PLoS One] 2008 Apr 23; Vol. 3 (4), pp. e2024. Date of Electronic Publication: 2008 Apr 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Germ-Line Mutation*
BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Breast Neoplasms/*epidemiology
Breast Neoplasms/*genetics
Adult ; Age of Onset ; Family ; Female ; Humans ; Malaysia/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Mohd Taib NA"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji